These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22477764)

  • 21. Right coronary artery perforation extending to the coronary sinus of Valsalva during percutaneous intervention successfully sealed with polytetrafluoroethylene-covered stent: a case report.
    Nasrin S; Cader FA; Haq MM; Karim MR
    BMC Res Notes; 2017 Oct; 10(1):537. PubMed ID: 29084606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
    Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
    Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation.
    Copeland KA; Hopkins JT; Weintraub WS; Rahman E
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):53-7. PubMed ID: 21953680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
    Utunomiya M; Katoh O; Nakamura S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
    Lansky AJ; Ng VG; Mutlu H; Cristea E; Guiran JB; Midei M; Newman W; Sanz M; Sood P; Doostzadeh J; Su X; White R; Cao S; Sudhir K; Stone GW
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):719-27. PubMed ID: 19530147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A simple but very complicated angioplasty: management of coronary artery perforation and dual antiplatelet therapy. A case report and literature review].
    Soriano F; Oreglia J; Bossi I; Colombo P; Piccalò G; De Marco F; Bruschi G; Klugmann S
    G Ital Cardiol (Rome); 2015 May; 16(5):311-5. PubMed ID: 25994468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
    Siontis GC; Stefanini GG; Mavridis D; Siontis KC; Alfonso F; Pérez-Vizcayno MJ; Byrne RA; Kastrati A; Meier B; Salanti G; Jüni P; Windecker S
    Lancet; 2015 Aug; 386(9994):655-64. PubMed ID: 26334160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty, and coronary artery bypass graft.
    Ishikawa K; Aoyama Y; Kato K; Tanaka A; Hiramatsu M; Ajioka M; Kamiya H; Tanaka T; Hirayama H
    J Card Surg; 2013 Mar; 28(2):97-101. PubMed ID: 23347085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).
    Jensen LO; Thayssen P; Hansen HS; Christiansen EH; Tilsted HH; Krusell LR; Villadsen AB; Junker A; Hansen KN; Kaltoft A; Maeng M; Pedersen KE; Kristensen SD; Bøtker HE; Ravkilde J; Sanchez R; Aarøe J; Madsen M; Sørensen HT; Thuesen L; Lassen JF;
    Circulation; 2012 Mar; 125(10):1246-55. PubMed ID: 22308301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case report of very late stent thrombosis observed simultaneously in all three vessels 5 years after sirolimus-eluting stent implantation.
    Fukui S; Endo H; Nakajima S; Takahashi T; Nakamura A; Nozaki E
    Cardiovasc Interv Ther; 2014 Apr; 29(2):151-6. PubMed ID: 23918078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-catheter covered stenting: a novel approach to the treatment of large coronary artery perforations.
    Silver KH; Bauman WB; Berkovitz KE
    J Invasive Cardiol; 2003 Jun; 15(6):348-50. PubMed ID: 12777675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A late complication of coronary artery perforation during primary percutaneous coronary intervention: Coronary arteriovenous fistula.
    Karaman K; Karayakalı M; Arısoy A; Akar İ; Çelik A
    Turk Kardiyol Dern Ars; 2017 Dec; 45(8):739-743. PubMed ID: 29226895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency polytetrafluoroethylene-covered stent implantation to treat right coronary artery perforation during percutaneous coronary intervention.
    Yorgun H; Canpolat U; Aytemir K; Oto A
    Cardiol J; 2012; 19(6):639-42. PubMed ID: 23224929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
    Massberg S; Byrne RA; Kastrati A; Schulz S; Pache J; Hausleiter J; Ibrahim T; Fusaro M; Ott I; Schömig A; Laugwitz KL; Mehilli J;
    Circulation; 2011 Aug; 124(5):624-32. PubMed ID: 21768546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug-eluting balloon in the treatment of a recurrent in-stent restenosis of drug-eluting stent].
    Merkely B; Jambrik Z
    Orv Hetil; 2010 Sep; 151(37):1509-14. PubMed ID: 20807698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report.
    Sakamoto S; Kikuchi N; Ichikawa A; Sano G; Satoh K; Sugino K; Isobe K; Takai Y; Shibuya K; Homma S
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1151-4. PubMed ID: 22983698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.